Advertisement
Research Article

Two Key Residues in EphrinB3 Are Critical for Its Use as an Alternative Receptor for Nipah Virus

  • Oscar A Negrete,

    Affiliation: Department of Microbiology, Immunology and Molecular Genetics, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America

    X
  • Mike C Wolf,

    Affiliation: Department of Microbiology, Immunology and Molecular Genetics, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America

    X
  • Hector C Aguilar,

    Affiliation: Department of Microbiology, Immunology and Molecular Genetics, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America

    X
  • Sven Enterlein,

    Affiliation: University of Texas Medical Branch, Galveston, Texas, United States of America

    X
  • Wei Wang,

    Affiliation: Department of Medicine-Infectious Diseases, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America

    X
  • Elke Mühlberger,

    Affiliation: Institute for Virology, Philipps-University Marburg, Marburg, Germany

    X
  • Stephen V Su,

    Affiliation: Department of Microbiology, Immunology and Molecular Genetics, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America

    X
  • Andrea Bertolotti-Ciarlet,

    Affiliation: Department of Microbiology, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America

    X
  • Ramon Flick,

    Affiliation: University of Texas Medical Branch, Galveston, Texas, United States of America

    X
  • Benhur Lee mail

    To whom correspondence should be addressed. E-mail: bleebhl@ucla.edu

    Affiliations: Department of Microbiology, Immunology and Molecular Genetics, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America, Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America, UCLA AIDS Institute, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America

    X
  • Published: February 10, 2006
  • DOI: 10.1371/journal.ppat.0020007

About the Authors

Oscar A Negrete, Mike C Wolf, Hector C Aguilar, Stephen V Su, Benhur Lee
Department of Microbiology, Immunology and Molecular Genetics, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America
Sven Enterlein, Ramon Flick
University of Texas Medical Branch, Galveston, Texas, United States of America
Wei Wang
Department of Medicine-Infectious Diseases, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America
Elke Mühlberger
Institute for Virology, Philipps-University Marburg, Marburg, Germany
Andrea Bertolotti-Ciarlet
Department of Microbiology, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America
Benhur Lee
Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America
Benhur Lee
UCLA AIDS Institute, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America

Corresponding Author

Email: bleebhl@ucla.edu

Competing Interests

The authors have declared that no competing interests exist.

Author Contributions

OAN and BL conceived and designed the experiments. OAN, MCW, SE, WW, and SVS performed the experiments and analyzed the data. OAN, HCA, EM, ABC, and RF contributed reagents/materials/analysis tools. OAN and BL wrote the paper.